Hemogenyx Pharmaceuticals

Hemogenyx Pharmaceuticals plc is a pre-clinical stage biopharmaceutical group focused on developing new drugs and therapies for the treatment of blood and autoimmune diseases, aiming to bring the curative potential of bone marrow transplantation to more patients suffering from life-threatening conditions that currently have no cure. The company is developing several distinct yet complementary products, as well as a platform technology that will serve as an engine for novel product development.